Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?

Immune checkpoint inhibitors (ICI) have been used as immunotherapy for hepatocellular carcinoma (HCC) with promising but still limited results. Identification of immune elements in the tumor microenvironment of individual HCC patients may help to understand the correlations of responses, as well as...

Descripción completa

Detalles Bibliográficos
Autores principales: Repáraz, David, Aparicio, Belén, Llopiz, Diana, Hervás-Stubbs, Sandra, Sarobe, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875127/
https://www.ncbi.nlm.nih.gov/pubmed/35216137
http://dx.doi.org/10.3390/ijms23042022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875127/
https://www.ncbi.nlm.nih.gov/pubmed/35216137
http://dx.doi.org/10.3390/ijms23042022

Ejemplares similares